Nieves v. This and That Services Co.

• Court: Superior Court of Delaware
• Decided: August 10, 2022
• Docket: S21A-11-004 CAK
• Status: Published

Opinion

IN THE SUPERIOR COURT OF THE STATE OF DELAWARE

RAYMOND NIEVES, : Claimant Below-Appellant, : C. A. No. S21A-11-004 CAK v. : THIS AND THAT SERVICES CO., : Employer Below-Appellee. :

Submitted: June 29, 2022 Decided: August 10, 2022

On Appeal from Industrial Accident Board REVERSED

MEMORANDUM OPINION AND ORDER

Walt F. Schmittinger, Esquire, Schmittinger and Rodriguez, P.A., 414 South State Street, Dover, DE 19903

John J. Ellis, Esquire, Heckler and Frabizzio, 800 Delaware Avenue, Suite 200, Wilmington, DE 19899

KARSNITZ, R.J. This is my second bite of the apple in this case. In a previous iteration I

reversed an Order of the Industrial Accident Board.1

In my opinion in Nieves I, I decided the Board improperly dismissed the

Employer’s petition challenging a Utilization Review2 decision approving the

prescription of narcotic medication for the appellee, an injured worker qualified to

receive workers’ compensation benefits.3 Employer believed the prescription of

narcotic medication was medically inappropriate; the utilization reviewer found

otherwise; and the Employer petitioned the Industrial Accident Board for its view

and decision.4

Claimant’s doctor originally prescribed the medication in June of 2017.

Between the time the Employer filed its petition challenging the Utilization

Review and the hearing before the Industrial Accident Board, Claimant was

referred for surgery. The surgical referral was in August 2017, and the Board

hearing was in September 2018.

Prior to the Board hearing, Claimant filed a motion in limine to limit

Employer’s petition to the period from June 13, 2017 through August 23, 2017 and

1 This and That Services Co, Inc. v. Nieves, 2019 WL 2406654 (Del. Super. June 7, 2019), rearg. den., 2019 WL 2539268 (Del. Super. June 19, 2019) (“Nieves I”) 2 See 19 Del. C. §2322F (j). 3 See 19 Del. C. Ch. 23. 4 Such a petition is often colloquially called an appeal of a Utilization Review decision. Technically it is not an appeal. Christiana Care Health Service v. Palomino, 74 A. 3d 627 (Del. 2013). to dismiss the issues as moot. The Board granted the motion and the Employer

appealed.

I reversed. For me, a small issue remained for the Board to decide, to wit:

was the June 2017 prescription for narcotics medically warranted? While that

issue seemed from a financial point of view a minor one, I believed it to be a viable

dispute. I was asked by way of motion for reargument to limit the scope of any

hearing on remand. Perhaps mistakenly, I thought Claimant was asking me to limit

what evidence could be presented on the limited issue I saw as viable. I denied

that request.

On remand, Claimant developed evidence that Employer had actually paid

for the contested prescription, a fact which Employer conceded in the argument I

held in this case.5 But time flowed on, and the hearing on remand morphed from

the issue of the narcotic prescription in June 2017, to more generally narcotic

prescriptions following the surgical procedure. The Board, after hearings on the

issue of narcotic prescriptions going forward, issued an opinion determining that

narcotic medication post-surgery was not reasonable and necessary, and that the

Employer was not financially responsible for it.

Claimant contends no such prescriptions are an issue currently. This

contention is muddied by evidence from Claimant’s physician’s records that he

5 Had this information been part of the record on the initial appeal, I would have affirmed the Board decision. prescribed the narcotic medication. The doctor’s records apparently show post-

surgical narcotic prescriptions. Claimant says he was not prescribed narcotics

(except in conjunction with his surgical recovery which no one challenges), he has

not taken any such medication, has not paid for it, and has not and will not seek

reimbursement for it.

Despite this state of affairs, the parties proceeded forward to hearing. The

Board conducted that hearing on two dates, June 3, 2021, and October 8, 2021.

The Board decided that any narcotic medication for Claimant is not reasonable and

necessary, and as a result not Employer’s responsibility. The Claimant has

appealed the Board decision.

STANDARD OF REVIEW

I am to review the Board’s decision for legal error.6 I give deference to the

Board’s factual findings supported by an appropriate factual record.7

Were I looking at only the record evidence in support of the Board’s finding,

I would affirm. The Board accepted the Employer’s expert testimony concerning

the appropriateness of narcotic medication, as it was entitled to do.8

But a legal issue lurks within the Board’s decision. If Claimant is making no

claim for medical expenses for a treatment, can the Employer still litigate the

6 Roos Foods v. Guardo, 152 A.2d 114, 118 (Del. 2016) 7 Id. 8 Compare, for example, Sheppard v. Allen Family Foods, No. 346, 2021 (Del. 2022) which affirmed the Superior Court’s affirmance of a Board decision on the issue of the appropriateness of narcotic medication. question. In other words, if there is no claim, does an Employer still have legal

standing to litigate an issue, or alternatively, is the issue moot. Not surprisingly,

the Claimant and the Employer take opposite views.

A PRELIMINARY ISSUE – APPEAL v. PETITION

The parties spend substantial time and effort debating if a petition

challenging a Utilization Review decision is an appeal or a separate petition before

the Board. A petition challenging a Utilization Review decision is a de novo

review, and our Supreme Court in a divided opinion determined petitions

challenging Utilization Reviews are not appeals.9 According to Employer, this

difference allowed it to expand the Board’s review beyond the sole issue I

originally considered, that is, the June 2017 prescription, to include post-surgical

prescriptions for narcotics.

In Employer’s view the designation of petition as a de novo review, rather

than an appeal, allows for the expansion of the review from its original intent (i.e.,

solely the June 2017 prescription). In my view the Employer’s conclusion does

not follow from its premise. The distinction made is not controlling over the

mootness or standing issue.

9 Christiana Care Health Service v. Palomino, 74 A.3d at, 632. THE PROCESS WAS SHORT CIRCUITED AND NO ISSUE WAS PROPERLY BEFORE THE BOARD

Utilization Review proceedings address a claim to certain specific medical

treatments. When new or subsequent claims are made the Utilization Review

process can and should be used again.10 In cases where a medical invoice pertains

to an acknowledged compensable claim it shall be referred to Utilization Review.11

The reason for this requirement is to allow for speedy review and resolution. For

this reason alone, the Board should not have considered the Employers’ claim to

review ongoing narcotic medication.

A second and equally important reason is that the Claimant had made no

claims for payment of ongoing medical claims. Indeed, the Claimant testified he

had no such bills. The evidence on this issue was murky at best, with the

Employer showing in medical records that prescriptions existed. This dispute of

fact, for me, re-enforces the concepts that Claimant should tender bills, allow a

response from the Employer, and if disputed engage in the Utilization Review

process. Without this process nothing is in dispute and nothing is justiciable.

10 19 Del C. §2322F(h). 11 Id. Employer correctly points out that at times the Board can decide non-

monetary issues. That is not the case when the dispute is over medical bills, which

here were non-existent.

The Employer has every right to use the process of Utilization Review,

followed by a petition to the Board to test the legitimacy of medical bills,

especially prescriptions for narcotic medication. But bills must be at issue, and

they were not here. The Board erred when it took it upon itself to decide issues not

before it.

The sole issue in my remand was the legitimacy of the June 2017

prescription for narcotic medication. The parties resolved that issue by Employer’s

payment. Nothing else was left.

I reverse the Board’s decision and remand the case to be dismissed. The

dismissal is without prejudice to either Claimant’s right or the Employer’s right to

contest medical bills which may be presented for periods after June 2017.

IT IS SO ORDERED.

/s/ Craig A. Karsnitz Craig A. Karsnitz

cc: Prothonotary